Spirochaetales Infections: Clinical Trials

35 trials for Spirochaetales Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 8 recruiting, 2 active not recruiting, 1 enrolling by invitation. 35 Phase 2, 9 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 235Completed 21, Recruiting 8, Active not recruiting 2, Enrolling by invitation 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 19Completed 5, Recruiting 2, Unknown 1, Withdrawn 1
Phase 33Completed 2, Terminated 1

Follow Spirochaetales Infections: new trials by email Literature Review of Spirochaetales Infections trials Research Report on Spirochaetales Infections

Trials (filtered) newest first · largest first

All 35 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy Patients
VM100 Nutritional Supplement - Duchenne Muscular Dystrophy, Duchenne Disease
Phase 2RecruitingUniversity of Florida202026-07-272026-10-08
Ceftriaxone for Post-Treatment Lyme Disease
Ceftriaxone treatment, Placebo - Post-Treatment Lyme Disease Syndrome
Phase 1 / Phase 2WithdrawnHackensack Meridian Health2026-05-142026-05-18
Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis
Linezolid (LZD), Amoxicillin, Benzathine Penicillin G - Syphilis, Congenital
Phase 2RecruitingLondon School of Hygiene and Tropical Medicine902026-05-042026-10-22
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Participants (18 to 70 Years of Age)
mRNA-1982, Placebo - Lyme Disease
Phase 2Active not recruitingModernaTX, Inc.3662026-04-292026-08-03
A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure
TP-05 (lotilaner) Low Dose, TP-05 (lotilaner) High Dose, Placebo - Lyme Disease
Phase 2Active not recruitingTarsus Pharmaceuticals, Inc.7222026-03-092026-07-09
Evaluation of Antimicrobial Prophylaxis to Prevent Syphilis in Pregnancy in Patients at Risk in Rio de Janeiro, Brazil
Benzathine penicillin 2.4 million units, Counseling and intensified testing. - Congenital Syphilis
Phase 2RecruitingUniversity of California, Los Angeles5002025-09-242026-06-01
N-Acetylcysteine in Patients With Leptospirosis
N-acetylcysteine, Placebo - Leptospirosis
Phase 2CompletedDr Cipto Mangunkusumo General Hospital642025-08-302026-09-16
Daily Doxycycline for Early Syphillis
Doxycycline 200mg daily for 14 days - Syphilis
Phase 2RecruitingUniversity of Washington152025-03-032025-06-25
Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Lumbrokinase - Long Covid, Post-treatment Lyme Disease Syndrome
Phase 1 / Phase 2RecruitingIcahn School of Medicine at Mount Sinai1202024-10-092026-03-13
Peer Delivered HIV/Syphilis Self-Testing With Assisted Partner Notification Services
Peer distribution of self testking kits - HIV, Syphilis
Phase 2Enrolling by invitationMakerere University2002024-08-252025-01-24
Vasodilator and Exercise Study for DMD (VASO-REx)
Tadalafil, Placebo, Exercise Training - Duchenne Muscular Dystrophy, Duchenne Disease
Phase 2RecruitingUniversity of Florida502024-06-052026-05-15
Preventive Strategies for Early and Late Complications of Leptospirosis
Prophylactic Plasma Transfusion, Hemoperfusion, Extracorporeal Membrane Oxygenation - Leptospirosis
Phase 2RecruitingNational Kidney and Transplant Institute, Philippines6782024-04-122026-04-13
Linezolid for Syphilis Pilot Study
Group B, Linezolid 10d, Group A, Penicillin - Syphilis
Phase 2CompletedUniversity of Southern California242023-09-282026-11-04
A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age
mRNA-1975, mRNA-1982, Placebo - Lyme Disease
Phase 1 / Phase 2CompletedModernaTX, Inc.8072023-07-262026-07-30
A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05
Low Dose TP-05, High Dose TP-05, Placebo Comparator - Healthy Volunteer
Phase 2CompletedTarsus Pharmaceuticals, Inc.302022-12-122024-09-19
Tetracycline Treatment Tolerability Trial
Tetracycline 500 Mg, Placebo - Post-Treatment Lyme Disease
Phase 2CompletedJohns Hopkins University602022-11-022026-09-28
Human Immune Response to Ixodes Scapularis Tick Bites
Xenodiagnosis Ticks, skin biopsy, blood draw - Tick-borne Diseases, Tick Resistance
Phase 1 / Phase 2RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)602022-02-282026-09-22
Phase 2 Study Of VLA15, A Vaccine Candidate Against Lyme Borreliosis, In A Healthy Pediatric And Adult Study Population
VLA15, Placebo - Lyme Borreliosis
Phase 2CompletedPfizer6252021-03-082026-09-15
A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome
RLP, Placebo - Post-Lyme Disease Syndrome (PLDS)
Phase 2 / Phase 3CompletedOptimal Health Research1002019-11-292021-04-12
Trial Evaluating the Clinical Efficacy of Cefixime for Treatment of Early Syphilis in Non-pregnant Women
Cefixime, Benzathine penicillin 2.4 million units - Syphilis Female
Phase 1 / Phase 2UnknownWorld Health Organization1802019-11-222020-02-05

Showing 20 of 35. Sign in to see all of them.

Narrower conditions

Lyme Disease (12)  ·  Syphilis (9)  ·  Post-Lyme Disease Syndrome (6)  ·  HIV Infections (4)  ·  Borrelia Infections (3)  ·  Leptospirosis (3)  ·  Sexually Transmitted Diseases (3)  ·  Chlamydia Infections (2)  ·  Fatigue (2)  ·  Gonorrhea (2)  ·  Muscular Dystrophies (2)  ·  Muscular Dystrophy, Duchenne (2)  ·  Syphilis, Congenital (2)  ·  Tabes Dorsalis (2)  ·  Tick-Borne Diseases (2)

Broader conditions

Bacterial Infections (34)  ·  Bacterial Infections and Mycoses (34)  ·  Gram-Negative Bacterial Infections (34)  ·  Infections (34)  ·  Vector Borne Diseases (17)  ·  Tick-Borne Diseases (15)  ·  Borrelia Infections (14)  ·  Treponemal Infections (14)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Pathologic Processes (10)  ·  Urogenital Diseases (10)  ·  Communicable Diseases (9)  ·  Disease Attributes (9)  ·  Genital Diseases (9)

Interventions

Cefixime (2)  ·  Linezolid (2)  ·  Methods (2)  ·  Penicillin G (2)  ·  lotilaner (2)  ·  Acetylcysteine (1)  ·  Albendazole (1)  ·  Amoxicillin (1)  ·  Azithromycin (1)  ·  Blood Specimen Collection (1)  ·  Ceftriaxone (1)  ·  Counseling (1)  ·  Deamino Arginine Vasopressin (1)  ·  Dexamethasone (1)  ·  Diethylcarbamazine (1)

Sponsors

Pfizer (3)  ·  ModernaTX, Inc. (2)  ·  Optimal Health Research (2)  ·  Population Council (2)  ·  Tarsus Pharmaceuticals, Inc. (2)  ·  University of California, Los Angeles (2)  ·  University of Florida (2)  ·  Centers for Disease Control and Prevention (1)  ·  Dr Cipto Mangunkusumo General Hospital (1)  ·  Hackensack Meridian Health (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Johns Hopkins University (1)  ·  Lihir Medical Centre (1)  ·  London School of Hygiene and Tropical Medicine (1)  ·  Mahidol University (1)

Countries

United States (21)  ·  Brazil (2)  ·  Indonesia (2)  ·  Papua New Guinea (2)  ·  South Africa (2)  ·  Thailand (2)  ·  Belgium (1)  ·  Canada (1)  ·  Germany (1)  ·  Israel (1)  ·  Malawi (1)  ·  Philippines (1)  ·  Switzerland (1)  ·  Uganda (1)

Top investigators

Jeffrey D Klausner, MD MPH (2)  ·  Adriana R Marques, M.D. (1)  ·  Barbara A Castelnuovo, MD, MPH. PhD (1)  ·  Bindu Balani, MD (1)  ·  Brian A Fallon, MD (1)  ·  Brian Fallon, M.D. (1)  ·  Bridget Freyne (1)  ·  Charlotte E. Ellertson, MPA, Ph.D. (1)  ·  David Putrino, PhD, PT (1)  ·  David Tellalian, MD (1)  ·  Edna O Kara, MD (1)

Results publications

PMID 38830375, PMID 16837678, PMID 32522244, PMID 32818264, PMID 33298143, PMID 33640982, PMID 37262040, PMID 39029481, PMID 40265182, PMID 40294611, PMID 41213278, PMID 42086599, PMID 42680745, PMID 42848323

NIH funding

R01AI045468 (1), R01AI187414 (1), R01MH092226 (1), R21AR079755 (1)